ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

317
Analysis
Health CareChina
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
02 Feb 2025 06:15

(Mostly) Asia-Pac M&A: Sigma Healthcare Dropsuite, Japfa, Dada Nexus, Malaysia Airports, Sanyo Steel

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
497 Views
Share
bullishDropsuite Ltd
30 Jan 2025 10:30

Dropsuite (DSE AU): NinjaOne's A$5.90/Share Scheme

This is a clean deal. Trading tight at 3.1%/9.8% gross/annualised spread, assuming late May completion. If in, stay in. If small, illiquid arbs are...

Logo
546 Views
Share
bullishDada Nexus
29 Jan 2025 06:15

Dada Nexus (DADA US): JD.Com's US$2/ADS Non-Binding Offer

Given the indicative nature of JD.com's Offer, DADA is trading wide at a 11% gross spread to terms. I'd look to enter around here and on any pullback.

Logo
506 Views
Share
bullishRed Hawk Mining
28 Jan 2025 17:12

Red Hawk (RHK AU): Fortescue's Off-Market Offer

This is done. Trading tight at A$1.19/share. Payment under the Offer is 10 business days once unconditional. If in, stay in. If small, illiquid...

Logo
394 Views
Share
28 Jan 2025 12:53

Shandong Hi-Speed New Energy (1250 HK)'s Unconditional MGO Now Open

Assuming around mid-Feb payment, I'd pay up to HK$1.76/share. Don't expect a bump in terms. SDHG has taken advantage of Citic exiting.

Logo
482 Views
Share
x